Early Glycaemic Control in Type 2 Diabetes Patients After Bariatric Surgery; ECODABS
1 other identifier
observational
33
4 countries
8
Brief Summary
Describe and characterize the time-course for improvement in glucose control after bariatric surgery in obese patients with type 2 diabetes Compare these changes in glycemic control after different techniques for bariatric surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2012
Longer than P75 for all trials
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedFirst Submitted
Initial submission to the registry
March 17, 2020
CompletedFirst Posted
Study publicly available on registry
March 19, 2020
CompletedMarch 19, 2020
March 1, 2020
5.5 years
March 17, 2020
March 17, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Glucose control
the aim is to describe and characterize the time-course for improvement in glucose control after bariatric surgery in obese patients with type 2 diabetes
from day one to 2-3 weeks after surgery
Secondary Outcomes (1)
Changes in glycemic control
day one post op to 2-3 weeks after surgery
Study Arms (2)
Gastric by-pass
Roux-en-Y gastric bypass (RYGB); the stomach is divided with staplers to create a small gastric pouch, while the jejunum is divided 30 to 50 cm distal to the ligament of Treitz. The distal limb is then anastomosed to the small gastric pouch and a jejunojejunostomy is performed 50 to 150 cm distal from the gastrojejunostomy.
Sleeve gastrectomy
Sleeve gastrectomy reduces the stomach size by vertical stapling
Interventions
Eligibility Criteria
diabetes mellitus typ 2 and obesity
You may qualify if:
- Male and female type 2 diabetic patients
- Patients aged 18-65 years
- Diabetes treatment consisting of dietary measures or any of the following:
- Metformin
- Sulfonylurea
- Glinides
- Glitazones
- Acarbose
- Any type of insulin
- BMI ≥ 35 kg/m2
You may not qualify if:
- Active alcohol abuse
- Active psychiatric illness
- MODY (maturity onset diabetes of the young)
- Type 1 diabetes
- Diabetes treatment consisting of DPP IV-inhibitors or incretin mimetics
- Pregnancy and gestational diabetes
- Prior bariatric surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sahlgrenska University Hospitallead
- University Hospital, Antwerpcollaborator
- Universitair Ziekenhuis Brusselcollaborator
- Karolinska Institutetcollaborator
- Hospital San Carlos, Madridcollaborator
- University Hospital, Ghentcollaborator
- Imperial College Londoncollaborator
Study Sites (8)
Antwerp University Hospital
Antwerp, Edegem, B-2650, Belgium
Universitair Ziekenhuis
Brussels, Jette, B-1090, Belgium
Gent University Hospital
Ghent, B-9000, Belgium
Hospital Clinico San Carlos
Madrid, Spain
Sahlgrenska University Hospital
Gothenburg, 413 45, Sweden
Sahlgrenska University Hospital
Gothenburg, SE-41345, Sweden
Karolinska Institutet
Stockholm, SE-116 91, Sweden
South kensington campus
London, SW7 2AZ, United Kingdom
Biospecimen
Plasma Serum
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ville Wallenius, Ass. Prof.
Sahlgrenska University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ass.Prof.
Study Record Dates
First Submitted
March 17, 2020
First Posted
March 19, 2020
Study Start
September 1, 2012
Primary Completion
March 1, 2018
Study Completion
March 1, 2018
Last Updated
March 19, 2020
Record last verified: 2020-03